A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy
- PMID: 28296410
- DOI: 10.1021/acs.molpharmaceut.7b00015
A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy
Abstract
In this study, the photochemical internalization (PCI) technique was adopted in a nanoparticle-based antigen delivery system to enhance antigen-specific CD8+ T cell immune response for cancer immunotherapy. Pheophorbide A, a hydrophobic photosensitizer, grafted with polyethylenimine (PheoA-PEI) with endosome escape activity and near-infrared imaging capability was prepared. A model antigen ovalbumin (OVA) was then complexed with PheoA-PEI to form PheoA-PEI/OVA nanoparticles (PheoA-PEI/OVA NPs) that are responsive to light. Flow cytometry analysis revealed increased endocytosis in a murine dendritic cell line (DC2.4) that was treated with PheoA-PEI/OVA NPs compared to free OVA. Generation of reactive oxygen species (ROS) in DC2.4 cells was also confirmed quantitatively and qualitatively using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA). Confocal laser scanning microscopy (CLSM) further demonstrated that the PheoA-PEI/OVA NPs enhanced cytosolic antigen release after light stimulation. Moreover, PheoA-PEI/OVA NP treated DC2.4 cells exhibited enhanced cross-presentation to B3Z T cell hybridoma in vitro after light irradiation, substantially increased compared to those treated with free OVA. Consistently, in vivo results revealed upregulation of CD3+CD8+T lymphocytes in tumors of mice treated with dendritic cells plus PheoA-PEI/OVA NPs and light irradiation. The activated T cell response is partly responsible for the inhibitory effect on E.G7 tumor growth in mice immunized with dendritic cells plus PheoA-PEI/OVA NPs and light irradiation. Our results demonstrate the feasibility to enhance antigen-specific CD8+ T cell immune response by light-responsive nanoparticle-based vaccine delivery for cancer immunotherapy.
Keywords: antigen delivery; cross-presentation; endosome escape; immunotherapy; photochemical internalization.
Similar articles
-
Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.Int J Nanomedicine. 2016 Aug 5;11:3753-64. doi: 10.2147/IJN.S110796. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27540289 Free PMC article.
-
Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation.Colloids Surf B Biointerfaces. 2021 Jan;197:111378. doi: 10.1016/j.colsurfb.2020.111378. Epub 2020 Sep 28. Colloids Surf B Biointerfaces. 2021. PMID: 33010719
-
Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.J Control Release. 2017 Jun 28;256:170-181. doi: 10.1016/j.jconrel.2017.04.020. Epub 2017 Apr 13. J Control Release. 2017. PMID: 28414151
-
Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.Acta Pharmacol Sin. 2019 Sep;40(9):1129-1137. doi: 10.1038/s41401-019-0281-1. Epub 2019 Aug 1. Acta Pharmacol Sin. 2019. PMID: 31371782 Free PMC article. Review.
-
Engineering nanoparticle strategies for effective cancer immunotherapy.Biomaterials. 2018 Sep;178:597-607. doi: 10.1016/j.biomaterials.2018.03.036. Epub 2018 Mar 21. Biomaterials. 2018. PMID: 29576282 Review.
Cited by
-
Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.Adv Sci (Weinh). 2021 Mar 1;8(8):2002499. doi: 10.1002/advs.202002499. eCollection 2021 Apr. Adv Sci (Weinh). 2021. PMID: 33898169 Free PMC article. Review.
-
Enhancement of Immune Responses Elicited by Nanovaccines through a Cross-Presentation Pathway.Tissue Eng Regen Med. 2023 Jun;20(3):355-370. doi: 10.1007/s13770-023-00527-y. Epub 2023 Mar 8. Tissue Eng Regen Med. 2023. PMID: 36884197 Free PMC article. Review.
-
Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists.Int J Mol Sci. 2021 Nov 19;22(22):12510. doi: 10.3390/ijms222212510. Int J Mol Sci. 2021. PMID: 34830392 Free PMC article. Review.
-
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy.Acta Pharm Sin B. 2020 Nov;10(11):2054-2074. doi: 10.1016/j.apsb.2020.08.010. Epub 2020 Aug 27. Acta Pharm Sin B. 2020. PMID: 33304779 Free PMC article. Review.
-
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses.Pharmaceutics. 2019 Nov 15;11(11):612. doi: 10.3390/pharmaceutics11110612. Pharmaceutics. 2019. PMID: 31731667 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous